|
United Front Against Riverblindness (UFAR) is a Non-Governmental Development Organization (NGDO)〔(Mectizan partners )〕 that provides technical, managerial and financial support for the elimination of riverblindness, or onchocerciasis, in the Kasongo region of Maniema province in the east-southern region of the Democratic Republic of the Congo (DRC). UFAR and its partners use the community-directed treatment with ivermectin (CDTI) approach recommended by the African Programme for Onchocerciasis Control (APOC), a branch of the World Health Organization (WHO). Each year UFAR ensures the treatment of about one million people in what is referred to as the CDTI Kasongo project to prevent the further transmission of the parasitic disease onchocerciasis to uninfected persons and to halt the progression of the disease in those already infected. ==History== United Front Against Riverblindness was formed in 2004 and recognized as a 501c3 by the U.S. Internal Revenue Service. The organization was founded by and is currently led by Executive Director Dr. Daniel Shungu. UFAR has a small headquarters office in Lawrenceville, NJ and operational offices in Kinshasa and Kasongo, DRC. The CDTI Kasongo includes eight health zones. In 2007 treatment was initiated in the health zone of Kasongo, in 2008 it was initiated in the health zones of Kunda, Lusangi, Salamabila and Samba,〔(UFAR Concludes Initial Treatment ), United Front Against Riverblindness news release〕 and in 2009 it was initiated in the remaining health zones of Kabambare, Kampene and Pangi.〔(UFAR Announces Plans to Treat Nearly One Million )〕 Since the community-wide mass treatment of all eligible people must be repeated once a year for 10–15 years, approximately three million tablets of Mectizan (ivermectin) were distributed in 2009 in all eight health zones by some 4,540 trained community workers. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「United Front Against Riverblindness」の詳細全文を読む スポンサード リンク
|